We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
LRVO | Larvotto Resources Ltd | 0.016 | 0.013 | 433.33% | 1,296,193 | 18 |
ICL | ICENI Gold Limited | 0.089 | 0.066 | 286.96% | 37,060,793 | 1,216 |
BRXO | Belararox Ltd | 0.002 | 0.001 | 100.00% | 240,335 | 1 |
AUNOC | Aurumin Limited | 0.002 | 0.001 | 100.00% | 627,024 | 2 |
ILAO | Island Pharmaceuticals Limited | 0.02 | 0.007 | 53.85% | 10,000 | 1 |
JAV | Javelin Minerals Ltd | 0.0015 | 0.0005 | 50.00% | 550,000 | 1 |
CT1 | Constellation Technologies Limited | 0.0015 | 0.0005 | 50.00% | 350,000 | 1 |
EUROB | European Lithium Limited | 0.006 | 0.002 | 50.00% | 285,000 | 3 |
PUA | Peak Minerals Limited | 0.003 | 0.001 | 50.00% | 1,884,715 | 5 |
LRV | Larvotto Resources Ltd | 0.105 | 0.033 | 45.83% | 32,709,629 | 1,007 |
AQX | Alice Queen Limited | 0.006 | 0.0015 | 33.33% | 3,238,457 | 8 |
Today, Luminar (NASDAQ: LAZR), a leading global automotive technology company, provided its quarterly business update and financial results for the first quarter of 2024. These results and related commentary were published in a Shareholder Letter that was issued via an 8-K SEC filing and published on its Investor Relations website at https://investors.luminartech.com.
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2024 financial results and provided business updates.
The date and time of the Company's previously announced conference call remains unchanged, and will be held on Wednesday, May 8, 2024, at 8:30 a.m. ET. The event will be webcast live and can be accessed at ir.tripadvisor.com. A replay will be available on the website for three months.
ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, today announced its first quarter ended March 31, 2024 financial results and updated its 2024 guidance. First Quarter Highlights Total revenue of $11.3 million in the first quarter of 2024, an increase of 32% over the first quarter of 2023.Core business revenue of $8.2 million in the first quarter of 2024, an increase of 5% over the first ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 62,537.07 | 197.35 | 0.32% | 1.23T | 3,167,154,401 |
ETH | Ethereum | 3,017.50 | 11.47 | 0.38% | 362.16B | 1,577,939,476 |
USDT | Tether USD | 0.99976 | -0.00024 | -0.02% | 97.82B | 203,299,175 |
BNB | Binance Coin | 585.04 | 7.64 | 1.32% | 92.26B | 221,928,027 |
SOL | Solana | 146.62 | -1.52 | -1.03% | 64.33B | 1,045,827,494 |
STETH | stETH | 3,019.84 | 13.51 | 0.45% | 29.55B | 6,693,489 |
XRP | Ripple | 0.5284 | 0.0035 | 0.67% | 28.79B | 325,467,793 |
USDC | USD Coin | 1.00 | 0.0001 | 0.01% | 28.07B | 765,744,174 |
DOGE | Dogecoin | 0.14915 | -0.00088 | -0.59% | 21.28B | 385,901,243 |
TONCOIN | Wrapped TON Coin | 5.80 | 0.137607 | 2.43% | 20.06B | 83,110,526 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions